Regenerative Medicine Attracted Record $20 Billion in Funding in 2020
Cell and gene therapy companies are quickly emerging as favorites of venture capital firms, investors and members of Big Pharma, according to a report from the Alliance for Regenerative Medicine.
Comment
expand_more
expand_less